Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
9
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1371/journal.pone.0252537.].
Identifiants
pubmed: 37943834
doi: 10.1371/journal.pone.0294382
pii: PONE-D-23-36149
pmc: PMC10635507
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0294382Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright: © 2023 Rounis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Références
PLoS One. 2021 Jun 1;16(6):e0252537
pubmed: 34061904